The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Pharmaceuticals Native Starch Market During 2026–2030?
The pharmaceuticals native starch market size has seen strong expansion in recent years. It is anticipated to increase from $6.11 billion in 2025 to $6.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. The historical growth in this market can be linked to the accessibility of natural starch sources, the proliferation of generic pharmaceuticals, the widespread adoption of tablets and capsules, the emphasis on cost sensitivity in drug formulation, and the regulatory acceptance of native starch.
The pharmaceuticals native starch market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $9.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the forecast period include the rise in clean-label drug formulations, stricter sustainability requirements, the expansion of pharmaceutical production facilities in developing regions, an increasing need for biodegradable excipients, and ongoing advancements in starch processing techniques. Key trends anticipated for this period encompass a surging demand for natural and clean-label excipients, their expanded application in solid oral dosage forms, their increasing role as binders and disintegrants, the broader development of plant-based pharmaceutical components, and a heightened emphasis on economically viable excipients.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp
Which Drivers Are Advancing The Pharmaceuticals Native Starch Market Growth?
The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market. These are enduring health issues that typically advance gradually and persist for at least a year. The growing incidence of chronic conditions is primarily linked to an expanding aging demographic, as older individuals are more prone to conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch contributes to managing chronic diseases by enhancing drug formulation stability, boosting bioavailability, facilitating controlled drug delivery, aiding patient adherence, and ultimately improving the efficacy and long-term management of these conditions. For example, the Centers for Disease Control and Prevention, a US federal public health agency, reported in April 2025 that 76.4% of U.S. adults, amounting to approximately 194 million people, had one or more chronic conditions in 2023. This prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increasing prevalence of chronic diseases is a key factor driving the pharmaceuticals native starch market’s growth. The growth in generic drug production is anticipated to boost the pharmaceuticals native starch market in the coming years. Generic drug manufacturing involves creating off-patent medications that possess the same bioequivalence as their branded counterparts. This rise in generic drug manufacturing is fueled by increased regulatory backing, which accelerates approval processes and motivates more companies to develop economical alternatives to proprietary drugs. The broadening of generic drug production aids pharmaceuticals native starch by heightening the need for dependable, economical excipients that improve tablet formulation, stability, and the effectiveness of drug delivery across a wider array of high-volume generic medications. For example, the Food and Drug Administration (FDA), a US federal agency, reported in November 2024 that it approved 782 Abbreviated New Drug Applications (ANDAs) in fiscal year 2023, an increase from 722 approvals in fiscal year 2022. Consequently, the expansion of generic drug manufacturing is a significant driver for the pharmaceuticals native starch market.
How Is Segment Classification Applied In The Pharmaceuticals Native Starch Market?
The pharmaceuticals native starch market covered in this report is segmented –
1) By Type: Potato Starch, Corn Starch, Other Types
2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users
Subsegments:
1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch
2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch
3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch
What Trends Are Impacting The Pharmaceuticals Native Starch Market?
Major companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-derived textures, to enhance drug formulation and improve patient adherence. Plant-based texture refers to the physical characteristics derived from plant ingredients, including thickness and gel strength, assisting pharmaceuticals in using native starch by improving tablet binding, disintegration, and mouthfeel for enhanced natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that boost drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.
Which Key Players Are Active In The Pharmaceuticals Native Starch Market?
Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.
Access The Complete Pharmaceuticals Native Starch Market Report:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report
Which Regional Market Leads The Pharmaceuticals Native Starch Market?
North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceuticals Native Starch Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp
Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company
Modified Starch Market Report 2026
https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report
Industrial Starch Market Report 2026
https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report
Starch Derivatives Market Report 2026
https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model